Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma

The efficacy of sorafenib in combination with transarterial chemoembolization (TACE) or multiple-line therapies in patients with advanced hepatocellular carcinoma (HCC) remains unclear. This study aimed to investigate the overall survival (OS) of patients with advanced HCC in response to different c...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Medicine (Baltimore)
Huvudupphovsmän: Hsiao, Pojen, Hsieh, Kun-Chou, Chen, Yaw-Sen, Hsu, Chia-Chang, Lo, Gin-Ho, Li, Yu-Chan, Hsieh, Pei-Min, Lin, Hung-Yu, Wu, Tsung-Chin, Yeh, Jen-Hao, Lin, Chih-Wen
Materialtyp: Artigo
Språk:Inglês
Publicerad: Wolters Kluwer Health 2019
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6636964/
https://ncbi.nlm.nih.gov/pubmed/31232945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016074
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk